Psychosis, Bipolar Disorder, Dopamine and Long-Term Monitoring

Antipsychotic Medications Explained: Benefits, Long-Term Risks and Biochemical Considerations

Antipsychotic medications can reduce hallucinations, delusions, mania, severe agitation and disorganized thinking. They may be lifesaving during acute instability, but long-term treatment requires careful attention to metabolic, hormonal, neurological and cardiovascular effects.

The goal is not merely to suppress visible behavior. Effective treatment should improve safety, sleep, judgment and daily function while minimizing weight gain, diabetes, movement disorders, sedation, hormonal disruption and loss of physical capacity.

What Are Antipsychotic Medications?

Antipsychotics are medications used primarily to reduce psychosis, including hallucinations, delusions, paranoia and severely disorganized thought or behavior.

They are also used in bipolar disorder, severe agitation, selected forms of depression, autism-related irritability and several other psychiatric or neurological situations.

Antipsychotic does not mean the patient is necessarily psychotic. Some medications in this group are prescribed for bipolar depression, mania, antidepressant augmentation, agitation, sleep or behavioral control.

How Do Antipsychotics Work?

Most antipsychotics reduce or regulate dopamine signaling, particularly through dopamine D2 receptors. Many second-generation medications also affect serotonin, histamine, adrenergic and muscarinic receptors.

A Simplified View of Antipsychotic Treatment
Psychosis or mania disrupts perception and judgment
Medication changes dopamine and related signaling
Hallucinations, delusions or agitation may decrease
Sleep and behavioral control may improve
Long-term risks require continued monitoring

Dopamine is not simply a “psychosis chemical.” It also participates in motivation, movement, pleasure, attention, learning, hormone regulation and normal goal-directed behavior.

This helps explain why excessive dopamine blockade can reduce psychosis while also causing stiffness, tremor, emotional flattening, low motivation, sexual dysfunction or elevated prolactin.

What Conditions Are Antipsychotics Used For?

Schizophrenia Schizoaffective disorder Acute mania Bipolar depression Psychotic depression Severe agitation Autism-related irritability Tourette syndrome Antidepressant augmentation Selected dementia-related agitation

Approved indications differ among medications. A drug approved for schizophrenia may not have the same approval or evidence for bipolar depression, autism-related irritability or dementia-related agitation.

Which Medications Are Antipsychotics?

Medication General characteristics Potential clinical uses Important concerns
Aripiprazole Dopamine partial agonist that may be less sedating or metabolically burdensome than some alternatives Schizophrenia, mania, bipolar maintenance, antidepressant augmentation and selected pediatric indications Akathisia, activation, insomnia, nausea and impulse-control problems in susceptible patients
Quetiapine Often sedating, with effects on dopamine, serotonin, histamine and adrenergic receptors Schizophrenia, mania, bipolar depression and selected antidepressant augmentation Sedation, dizziness, weight gain, glucose and lipid effects, falls and withdrawal-related insomnia
Risperidone Potent dopamine and serotonin effects, available in oral and long-acting forms Schizophrenia, bipolar mania and autism-related irritability Elevated prolactin, sexual effects, movement symptoms, weight gain and metabolic abnormalities
Olanzapine Often effective for acute mania and psychosis but associated with substantial appetite and metabolic effects Schizophrenia, mania, maintenance and selected bipolar or treatment-resistant depressive strategies Weight gain, insulin resistance, diabetes, lipid abnormalities and sedation
Ziprasidone Generally lower weight-gain burden than some alternatives Schizophrenia and acute manic or mixed bipolar episodes QT-interval prolongation, food-dependent absorption, akathisia and movement effects
Lurasidone Often selected when bipolar depression is prominent and metabolic effects are a concern Schizophrenia and depressive episodes associated with bipolar I disorder Akathisia, nausea, sedation and a meaningful food requirement for absorption
Clozapine A specialized medication for treatment-resistant schizophrenia and selected patients with persistent suicidality Severe illness that has not responded adequately to other antipsychotics Severe neutropenia, myocarditis, seizures, constipation or bowel obstruction, sedation, drooling and metabolic effects
Haloperidol First-generation medication with strong dopamine-receptor blockade Acute psychosis, mania, agitation and selected chronic psychotic disorders Dystonia, parkinsonism, akathisia, tardive dyskinesia and QT effects

What Is the Difference Between First- and Second-Generation Antipsychotics?

First-Generation Antipsychotics

Older medications generally rely more heavily on dopamine D2 blockade. Some have a greater tendency to produce stiffness, tremor, dystonia, akathisia and tardive dyskinesia.

Second-Generation Antipsychotics

Newer medications affect dopamine and serotonin in different proportions. Several have lower movement risk but greater potential for weight gain, diabetes and lipid abnormalities.

“Atypical” does not mean harmless. The side-effect burden often shifts from movement symptoms toward appetite, metabolic, hormonal, cardiovascular or sedative effects.

What Is a Dopamine Partial Agonist?

Aripiprazole, brexpiprazole and cariprazine are commonly described as dopamine partial agonists. They do not simply block the receptor in the same way as a strong dopamine antagonist.

A partial agonist activates a receptor less strongly than dopamine itself. Its functional effect may therefore differ depending on the dopamine environment and the brain pathway involved.

Potential Advantages

Some patients experience less sedation, prolactin elevation or metabolic burden than with selected alternatives.

Potential Activation

Restlessness, insomnia, internal tension and increased activity can be prominent.

Impulse-Control Effects

New gambling, compulsive shopping, binge eating or sexual urges require prompt medication review.

Why Do Antipsychotics Help During Mania or Psychosis?

During severe mania or psychosis, the patient may lose sleep, judgment, reality testing and behavioral control. Medication may reduce the intensity of abnormal signaling quickly enough to prevent injury, hospitalization, financial loss, aggression or prolonged neurological stress.

Hallucinations may decrease Voices, visions or other perceptions may become less frequent or less compelling.
Delusions may loosen Fixed false beliefs may become less intense, allowing better reality testing.
Sleep may return Restoring sleep can be essential during escalating mania or psychosis.
Agitation may decline Internal tension, pacing, aggression and dangerous impulsivity may improve.
Thinking may organize Speech and behavior may become more coherent and goal directed.
Safety may improve The patient may regain enough judgment to participate in further assessment and treatment.

Why Do Antipsychotics Cause Weight Gain and Metabolic Problems?

Several antipsychotics affect appetite, satiety, histamine signaling, insulin sensitivity, energy expenditure and activity. Weight may rise rapidly even when the patient does not perceive a dramatic dietary change.

Metabolic effects vary substantially among medications, but every patient deserves monitoring rather than an assumption that weight gain is caused only by poor discipline.

Increased Appetite

Hunger, carbohydrate cravings and reduced satiety may appear soon after treatment begins.

Insulin Resistance

Glucose regulation may worsen independently of visible weight gain.

Lipid Changes

Triglycerides and cholesterol may increase and contribute to cardiovascular risk.

Reduced Activity

Sedation, slowed movement and loss of motivation may reduce energy expenditure and muscle mass.

A normal starting weight does not eliminate metabolic risk. Glucose, hemoglobin A1c, triglycerides, waist size and blood pressure may worsen before obesity becomes obvious.

Diet should emphasize sufficient protein, minimally processed food, vegetables, healthy fats and controlled refined carbohydrate intake. Exercise should include walking or aerobic activity together with muscle strengthening whenever medically appropriate.

Which Movement Side Effects Can Antipsychotics Cause?

Acute Dystonia

Painful muscle contractions may affect the neck, jaw, eyes or other muscles and can occur soon after starting or increasing treatment.

Drug-Induced Parkinsonism

Stiffness, slowed movement, reduced facial expression, shuffling gait and tremor may resemble Parkinson disease.

Akathisia

Severe internal restlessness may produce pacing, inability to sit still, anxiety or desperate discomfort.

Tardive Dyskinesia

Repetitive involuntary movements may affect the mouth, tongue, face, trunk or limbs after longer exposure.

Movement monitoring should occur before treatment and periodically afterward. Patients and families may notice subtle changes before they become obvious during a brief office visit.

What Is Akathisia?

Akathisia is a medication-related state of intense internal restlessness. Patients may pace, rock, repeatedly cross their legs, feel unable to sit still or describe unbearable internal agitation.

It may be mistaken for anxiety, worsening mania, behavioral resistance or psychotic agitation. Increasing the antipsychotic dose without recognizing akathisia can make the problem worse.

Severe akathisia requires prompt assessment

Akathisia may be associated with extreme distress, aggression, medication refusal or suicidal thinking. New restlessness after starting or increasing an antipsychotic should be reported promptly.

What Is Tardive Dyskinesia?

Tardive dyskinesia is a potentially persistent movement disorder associated with dopamine-receptor-blocking medications. Risk generally increases with longer exposure and greater cumulative dose, although it can occur earlier.

Possible signs include:

  • Lip smacking or chewing movements
  • Tongue protrusion or twisting
  • Facial grimacing
  • Finger or hand movements
  • Rocking or irregular trunk movement
  • Unusual leg or foot movement

Early identification matters. The need for the medication, dose, alternative agents and treatments for tardive dyskinesia should be reviewed without abruptly destabilizing the psychiatric illness.

What Is Neuroleptic Malignant Syndrome?

Neuroleptic malignant syndrome is a rare but potentially fatal reaction associated with antipsychotic medications and other dopamine-altering drugs.

High fever Severe muscle rigidity Confusion Autonomic instability Rapid pulse Abnormal blood pressure Heavy sweating Elevated creatine kinase

Neuroleptic malignant syndrome is a medical emergency

Fever, severe rigidity, confusion and autonomic instability during antipsychotic treatment require emergency evaluation rather than a routine outpatient appointment.

How Do Antipsychotics Affect Prolactin and Sexual Function?

Dopamine normally restrains prolactin release. Strong dopamine blockade in relevant pathways can increase prolactin, particularly with certain medications.

Menstrual changes Cycles may become irregular or stop.
Breast changes Breast enlargement, tenderness or milk production may occur.
Sexual dysfunction Libido, arousal, erection or orgasm may be affected.
Fertility Elevated prolactin may interfere with normal reproductive hormone signaling.
Bone health Prolonged suppression of reproductive hormones may affect bone density.
Emotional effects Reduced dopamine signaling may contribute to low motivation or emotional flattening.

Prolactin testing is particularly useful when symptoms suggest hormonal disruption rather than as an automatic explanation for every sexual side effect.

Can Antipsychotics Cause Sedation or Cognitive Slowing?

Sedation can be useful during dangerous mania, psychosis or prolonged insomnia. It can become harmful when it prevents rehabilitation, exercise, school, employment, normal conversation or independent functioning.

Daytime Sleepiness

The patient may sleep adequately at night but remain unable to function during the day.

Slowed Thinking

Processing speed, working memory, speech and decision-making may appear impaired.

Fall Risk

Sedation, orthostatic blood-pressure changes and stiffness can increase falls, especially in older adults.

Reduced Exercise

Fatigue and low motivation may accelerate weight gain, muscle loss and insulin resistance.

Emotional Blunting

Reduced agitation may be beneficial, but excessive flattening can reduce pleasure, initiative and relationships.

Medication Accumulation

Aging, liver or kidney changes and drug interactions may make a previously tolerated dose more sedating.

Are Antipsychotics Safe for Older Adults With Dementia?

Antipsychotics require special caution in older adults with dementia. Medications in this class carry warnings about increased mortality in elderly patients with dementia-related psychosis. Stroke, sedation, swallowing difficulty, falls, infection and cardiovascular effects may contribute to risk.

Before treating agitation as a psychiatric symptom, the evaluation should consider pain, urinary infection, constipation, dehydration, medication toxicity, poor sleep, unfamiliar surroundings, low oxygen, glucose abnormalities and other causes of delirium or distress.

Dementia-related agitation is not automatically psychosis

Sedating an older patient without investigating the cause may conceal infection, pain, dehydration, medication accumulation or another reversible medical problem.

Brexpiprazole has a specific FDA-approved indication for agitation associated with dementia due to Alzheimer’s disease, but it retains the class boxed warning concerning increased mortality in elderly patients with dementia-related psychosis.

Related reading: Dementia as a Metabolic and Neurological Condition .

What Happens When an Antipsychotic Is Reduced Too Quickly?

Abrupt reduction may produce insomnia, anxiety, nausea, sweating, agitation, abnormal movements or rapid return of mania or psychosis. Symptoms may reflect withdrawal, relapse or both.

A patient who has taken an antipsychotic for years may require a more gradual and closely monitored taper than someone treated briefly for an acute episode.

The final dose reductions may be the most difficult. Lower doses can still produce meaningful receptor effects, and a fixed milligram reduction may represent a larger biological change near the end of a taper.

Which Tests and Measurements Are Used With Antipsychotics?

Test or measurement What it evaluates Why it matters
Weight and body-mass trend Medication-associated weight change Rapid early weight gain may predict increasing metabolic burden.
Waist circumference Central adiposity Abdominal fat is strongly related to insulin resistance and cardiovascular risk.
Fasting glucose and hemoglobin A1c Glucose regulation Detects diabetes or worsening glycemic control.
Fasting insulin when appropriate Early insulin resistance Insulin may rise before glucose or A1c becomes clearly abnormal.
Lipid panel Triglycerides and cholesterol Several medications may substantially worsen lipid status.
Blood pressure and pulse Cardiovascular and autonomic effects Detects hypertension, tachycardia or orthostatic changes.
CBC and comprehensive metabolic panel Blood cells, glucose, electrolytes, kidney and liver function Provides medical and medication-safety context.
Prolactin when indicated Hormonal effect of dopamine blockade Useful with menstrual, breast, fertility or sexual symptoms.
ECG when clinically indicated QT interval and cardiac rhythm Important with cardiac disease, interacting medications or medications with greater QT-related concern.
Structured movement examination Parkinsonism, akathisia and tardive dyskinesia Helps detect side effects before they become severe or persistent.
Clozapine blood monitoring Absolute neutrophil count and related safety parameters Clozapine requires specialized monitoring because of severe neutropenia and other serious risks.

How Can Walsh and Functional Testing Add to Antipsychotic Treatment?

Walsh and functional testing should not delay necessary treatment for psychosis or mania. It may identify biochemical and medical contributors that affect vulnerability, recovery, medication tolerance and long-term physical health.

Copper and Zinc Balance

Copper-related norepinephrine activity and low zinc may contribute to anxiety, agitation, insomnia and impaired stress tolerance.

Methylation

Whole-blood histamine, SAM, SAH, methionine and homocysteine may provide more context than an MTHFR result alone.

Oxidative Stress

Psychosis, inflammation, poor diet and medication-related metabolic dysfunction may increase oxidative demand.

Vitamin D and Nutrient Status

Deficiencies may affect immune health, muscle strength, mood, bone health and metabolic resilience.

Gut and Toxic Burden

Dysbiosis, malabsorption, constipation, food-related inflammation and impaired clearance may complicate treatment.

Mitochondrial and Metabolic Health

Glucose instability, low activity, poor sleep and inadequate protein may impair cognition and physical recovery.

A Walsh biotype does not diagnose schizophrenia or psychosis. The biochemical assessment identifies possible contributors and treatment barriers after safety and psychiatric stabilization have been addressed.

Review The Walsh Approach, Toxic Overload and laboratory testing.

Can Nutrition Reduce Antipsychotic Side Effects?

Nutrition cannot substitute for necessary antipsychotic treatment, but it may reduce some of the physical deterioration that occurs during long-term therapy.

Adequate protein Helps maintain muscle, satiety, neurotransmitter substrates and metabolic health.
Controlled refined carbohydrates May help limit glucose swings, triglycerides and medication-associated weight gain.
Strength training Supports muscle, insulin sensitivity, balance and functional independence.
Aerobic activity Supports cardiovascular health, glucose regulation, sleep and mood.
Zinc and vitamin D Measured deficiencies should be corrected while monitoring copper, kidney function and other relevant factors.
Creatine May support muscle and brain energy but should be interpreted alongside kidney status, hydration and the broader clinical picture.

Avoid starting multiple activating supplements during instability

SAMe, methionine, high-dose methylfolate and other activating products may worsen insomnia, mania, agitation or psychosis in susceptible patients.

Stabilize Before Considering Antipsychotic Reduction

Antipsychotics may be absolutely necessary during psychosis, mania, dangerous aggression, severe agitation, suicidal illness or inability to care for basic needs.

The preferred sequence is:

  1. Control acute psychosis, mania or dangerous behavior.
  2. Restore sleep, nutrition, hydration and medical safety.
  3. Determine which symptoms improved and which side effects developed.
  4. Review metabolic, hormonal, neurological and cardiovascular effects.
  5. Perform targeted biochemical and nutritional testing.
  6. Correct deficiencies and functional barriers gradually.
  7. Identify the lowest effective medication burden over time.
  8. Consider gradual reduction only after sustained stability and with the prescribing clinician.

Abrupt discontinuation may cause insomnia, agitation, withdrawal, psychotic relapse, mania, hospitalization or dangerous behavior.

The Second Opinion Physician Antipsychotic Medication Evaluation

Psychiatric Stability

  • Hallucinations, delusions and paranoia
  • Mania, agitation and aggression
  • Sleep and circadian disruption
  • Suicide risk and ability to perform self-care
  • Prior relapse after medication changes

Medication Response

  • Symptoms that improved
  • Sedation and cognitive effects
  • Akathisia and movement symptoms
  • Weight, appetite and glucose changes
  • Sexual and hormonal effects

Biochemical and Medical Factors

  • Copper, ceruloplasmin and zinc
  • Whole-blood histamine
  • SAM, SAH and homocysteine
  • Vitamin D and nutrient status
  • Glucose, insulin, lipids and organ function

Treatment Priorities

  • Maintain safety and psychiatric stability
  • Identify the lowest effective dose
  • Reduce metabolic and movement risks
  • Correct measured nutrient abnormalities
  • Restore exercise, muscle, sleep and daily function

Related Medication and Biochemistry Topics

Mental Health Medications Mood Stabilizers Explained Bipolar Disorder Choosing the Correct Antidepressant SSRIs Explained SNRIs Explained The Walsh Approach Copper Overload Undermethylation Overmethylation Elevated SAH Toxic Overload Creatine and Methylation Laboratory Testing Patient Questionnaires Consultation Options

Frequently Asked Questions About Antipsychotics

What do antipsychotic medications treat?

Antipsychotics are used primarily for psychosis, schizophrenia and mania. Selected medications are also used for bipolar depression, antidepressant augmentation, severe agitation and other conditions.

How do antipsychotics work?

Most antipsychotics block or regulate dopamine D2 receptors. Many also affect serotonin, histamine, adrenergic and muscarinic receptors, contributing to both therapeutic and adverse effects.

Why do antipsychotics cause weight gain?

Some antipsychotics increase appetite and alter satiety, insulin sensitivity, lipid regulation, activity and energy expenditure.

Can antipsychotics cause diabetes?

Several antipsychotics can worsen glucose regulation and insulin resistance. Weight, glucose, hemoglobin A1c and lipids should be monitored.

What is akathisia?

Akathisia is severe internal restlessness that may cause pacing and an inability to sit still. It can be mistaken for anxiety or worsening psychiatric illness.

What is tardive dyskinesia?

Tardive dyskinesia is a potentially persistent movement disorder involving involuntary movements of the mouth, tongue, face, trunk or limbs after exposure to dopamine-receptor-blocking drugs.

What is neuroleptic malignant syndrome?

Neuroleptic malignant syndrome is a rare medical emergency that may involve high fever, severe rigidity, confusion, autonomic instability and elevated creatine kinase.

Can antipsychotics raise prolactin?

Yes. Dopamine blockade can increase prolactin and contribute to menstrual changes, breast symptoms, sexual dysfunction, fertility problems and reduced bone health.

Are antipsychotics safe for dementia?

Antipsychotics carry warnings about increased mortality in elderly patients with dementia-related psychosis. Reversible causes of agitation should be investigated before relying on sedation.

Should an antipsychotic be stopped if weight or glucose increases?

Not abruptly. Psychiatric benefit, metabolic risk, dose, alternative medications and prior relapse should be reviewed with the prescribing clinician.

Can nutrients replace an antipsychotic?

Nutrients may address contributing biochemical abnormalities but should not replace necessary medication during psychosis, mania, dangerous aggression or severe instability.

How should an antipsychotic be discontinued?

Reduction should be gradual, individualized and supervised by the prescribing clinician after sustained stability. Abrupt withdrawal can cause severe insomnia, agitation, mania or psychotic relapse.

Reviewing Antipsychotic Benefits and Long-Term Risks

A detailed history and laboratory review may clarify metabolic, neurological, hormonal, nutritional and biochemical factors affecting medication safety and recovery.

Patient Questionnaires Laboratory Testing Consultation Options

Selected Sources and Further Reading

  1. U.S. Food and Drug Administration. Current prescribing information for aripiprazole, including indications, akathisia, metabolic monitoring, impulse-control concerns and the dementia-related psychosis warning.
  2. U.S. Food and Drug Administration. Current prescribing information for quetiapine, including schizophrenia, bipolar indications, metabolic changes, sedation and dementia-related psychosis warnings.
  3. U.S. Food and Drug Administration. Current prescribing information for risperidone, including movement, prolactin, metabolic and dementia-related risks.
  4. U.S. Food and Drug Administration. Antipsychotic class warning regarding increased mortality in elderly patients with dementia-related psychosis.